In-Housing Omnichannel Orchestration

Overview

Life sciences companies are rethinking how they allocate capital and resources for omnichannel orchestration. Early investments prioritized speed: fully outsourced, packaged orchestration products that could be stood up quickly and demonstrate immediate value to commercial teams. That approach worked, at first, but expectations have changed.

Orchestration is no longer viewed as a static capability or a point solution. It must evolve continuously, adapt to changing brands and channels, reuse enterprise customer context, and operate with clear governance across commercial, medical, and digital teams.

As a result, orchestration is increasingly being brought in-house. This shift is not about slowing down innovation. It’s about establishing orchestration as a core enterprise capability, one that is scalable, governable, and deeply connected to the organization’s data, platforms, and operating model.

This point of view outlines:

• Why orchestration is moving in-house as maturity increases.
• What a practical target architecture looks like for life sciences organizations.
• How to migrate safely without disrupting field execution or digital programs.